Cochrane Review: Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post-COVID-19 condition

Zusammenfassung

Plasmapherese zur Entfernung von Amyloidfibrin(ogen)partikeln zur Behandlung der Post‐COVID‐19‐Erkrankung - Fox, T - 2023 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015775/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015775/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions

Kerninformationen

ane Database of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention Collapse all Expand all ## Abstract available in ### Background The post‐COVID‐19 condition (PCC) consists of a wide array of symptoms including fatigue and impaired daily...

e amyloid and include fibrin(ogen); amyloid is not a part of a thrombus which is a mix of fibrin mesh and platelets. Initial acute COVID‐19 infection is associated with clotting abnormalities; this review concerns amyloid fibrin(ogen) particles in PCC only. We have reported here our appraisal of la...

cles in individuals with PCC from randomized controlled trials. ### Search methods **Laboratory studies review** We searched for all relevant laboratory studies up to 27 October 2022 using a comprehensive search strategy which included the search terms ‘COVID’, ‘amyloid’, ‘fibrin’, ‘fibrinogen’. ...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen